JESSIE SURLA: Open Payments
NPI 1245656479 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 56 payments from 12 companies in 2025. Trend: 2023 $434 · 2024 $460 · 2025 $1,133
Food & beverage: $925Education: $208
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $336 |
| PFIZER INC. | 6 | $153 |
| Gilead Sciences, Inc. | 6 | $113 |
| Ipsen Biopharmaceuticals, Inc | 6 | $110 |
| Janssen Biotech, Inc. | 2 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| Ardelyx, Inc. | 3 | $71 |
| Madrigal Pharmaceuticals | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Celltrion USA Inc. | 1 | $21 |
Products named: MAVYRET, VELSIPITY, IQIRVO, SKYRIZI, TREMFYA, ENTYVIO, IBSRELA, RINVOQ.
Industry payments across NM — which companies pay providers there.
